ACELYRIN
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4149 Liberty Canyon Rd, Agoura Hills, Ca...Phone Number
(805) 730-0360Website
www.acelyrin.comRevenue
$375.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About ACELYRIN
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. The company was founded in 2020 and is headquartered in Agoura Hills, California.Explore more
ACELYRIN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ACELYRIN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if ACELYRIN is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at ACELYRIN
Product Launch: Get notified when ACELYRIN launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ACELYRIN recently announced quarterly report
ACELYRIN, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ACELYRIN has new funding data
Check if ACELYRIN has recently received funding, and reach out quickly before it becomes old news!
Click to see if ACELYRIN had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined ACELYRIN as Masked Content
Find 2 more new buyers
Compare Similar Companies to ACELYRIN
Compare insights from companies similar to ACELYRIN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ACELYRIN is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ACELYRIN is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ACELYRIN.
ACELYRIN financials insights
Gather financial insights about ACELYRIN, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$250M
2022
Series C
$300M
2023
Stock Offering
$540M
ACELYRIN Tech Stack
A closer look at the technologies used by ACELYRIN
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
ACELYRIN News & Media
ACELYRIN Stockholders Approve Merger with Alumis to Create - GlobeNewswire
LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the...Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction TodayAcelyrin urges stockholders to vote for proposed merger with Alumis
ACELYRIN (SLRN) reiterated its confidence that the proposed combination with Alumis (ALMS) is the best path forward and the most value-maximizing outcome for all ACELYRIN stockholders. Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the independent transaction committee, said, “The ACELYRIN Board and management team are confident that the proposed merger with Alumis represents the most value-maximizing path forward for our company’s stockholders. The agreement with Alumis foACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis
Special Meeting of stockholders to vote on the transaction scheduled for May 13, 2025
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ACELYRIN
Sign Up For FreeTo access detailed company insights
ACELYRIN, INC. is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. The company was founded in 2020 and is headquartered in Agoura... Read More
